A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors
Qin, Lingyun2,3; Zhou, Jingjing2,3; Su, Zhengding2,3; Liu, Huili1; Huang, Yongqi2,3; Chen, Yao2,3; Chen, Rong2,3
刊名BIOCHEMISTRY
2017-06-27
卷号56期号:25页码:3273-3282
DOI10.1021/acs.biochem.7b00085
文献子类Article
英文摘要In nearly half of cancers,. the anticancer activity of p53 protein is often impaired by the overexpressed oncoprotein Mdm2 and its homologue, MdmX, demanding efficient therapeutics to disrupt the aberrant p53-MdmX/Mdm2 interactions to restore the p53 activity. While many :potent Mdm2-specific inhibitors have already :undergone clinical investigations, searching for MdmX-specific inhibitors has become very attractive, requiring a more efficient screening strategy for evaluating potential scaffolds or leads. In this work, considering that the intrinsic fluorescence residue Trp23 in the p53 transaction domain (p53p) plays an important role in determining the p53-MdmX/Mdm2 interactions, we constructed a fusion protein to utilize this intrinsic fluorescence signal to monitor high-throughput screening of a compound library. The fusion protein was composed of the p53p followed, by the N-terminal domain of MdmX (N-MdmX) through a flexible amino acid linker, while the whole fusion protein contained a sole intrinsic fluorescence probe. The fusion protein was then evaluated using fluorescence spectroscopy against model compounds. Our results revealed that the variation of the fluorescence signal was highly correlated with the concentration of the ligand within 65 The fusion protein was further evaluated with respect to its feasibility for use in high-throughput screening using a model compound library; including controls. We found that the imidazo-indole scaffold was a bona fide scaffold for template-based design of MdmX inhibitors. Thus, the p53p N-MdmX fusion protein we designed provides a convenient and efficient tool for high-throughput screening of new MdmX inhibitors. The strategy described in this work should be applicable for other protein targets to accelerate drug discovery.
WOS关键词SMALL-MOLECULE INHIBITOR ; DRUG DISCOVERY ; CANCER ; P53-MDM2 ; PATHWAY ; IDENTIFICATION ; OPPORTUNITIES ; INACTIVATION ; ANTAGONISTS ; VALIDATION
WOS研究方向Biochemistry & Molecular Biology
语种英语
WOS记录号WOS:000404493000012
资助机构Wuhan Natural Science Foundation(201506101010033) ; Wuhan Natural Science Foundation(201506101010033) ; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics(T152604) ; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics(T152604) ; NSFC(31500132 ; NSFC(31500132 ; 210603121) ; 210603121) ; Wuhan Natural Science Foundation(201506101010033) ; Wuhan Natural Science Foundation(201506101010033) ; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics(T152604) ; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics(T152604) ; NSFC(31500132 ; NSFC(31500132 ; 210603121) ; 210603121)
内容类型期刊论文
源URL[http://ir.wipm.ac.cn/handle/112942/11474]  
专题武汉物理与数学研究所_高技术创新与发展中心
作者单位1.Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Natl Ctr Magnet Resonance Wuhan, Wuhan 430071, Hubei, Peoples R China
2.Hubei Univ Technol, Minist Educ, Inst Biomed & Pharmaceut Sci, Wuhan 430068, Hubei, Peoples R China
3.Hubei Univ Technol, Minist Educ, Key Lab Ind Fermentat, Wuhan 430068, Hubei, Peoples R China
推荐引用方式
GB/T 7714
Qin, Lingyun,Zhou, Jingjing,Su, Zhengding,et al. A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors[J]. BIOCHEMISTRY,2017,56(25):3273-3282.
APA Qin, Lingyun.,Zhou, Jingjing.,Su, Zhengding.,Liu, Huili.,Huang, Yongqi.,...&Chen, Rong.(2017).A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors.BIOCHEMISTRY,56(25),3273-3282.
MLA Qin, Lingyun,et al."A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors".BIOCHEMISTRY 56.25(2017):3273-3282.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace